AlphaHunt
Healthcare

ELV Stock Analysis

Elevance Health, Inc. · current price $391.26 (-1.66% today)

★★★ Average 56/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS Elevance Health, Inc. (ELV)

Latest earnings

EPS
$8.84 vs $8.92 est · -0.0% vs estimate MISS
Revenue
$50.18B · +0.8% YoY
Stock reaction (1M)
-0.4%
Beat streak
3 of last 4 quarters

Key metrics

Alpha Score
56/100
Grade
C
Rev Growth YoY
+2.6%
30-day Momentum
-0.4%
Forward P/E
16.6×
Analyst Target
$415.81
Implied Upside
+6.3%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

ELV — frequently asked

What is ELV's Alpha Score?

Elevance Health, Inc. (ELV) currently has a TickerMover Alpha Score of 56/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Elevance Health, Inc. (ELV) a buy?

TickerMover does not give buy or sell recommendations. ELV scores 56/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ELV's score updated?

ELV's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for ELV →